Opening Doors to Your Future Career in Medical Affairs
The MAPS 2023 Annual Meeting in New Orleans will host a Young Professionals and Future Leaders Reception session on Tuesday March 28. Download the session handout here:
The MAPS 2023 Annual Meeting in New Orleans will host a Young Professionals and Future Leaders Reception session on Tuesday March 28. Download the session handout here:
The Medical Affairs Professional Society (MAPS) is honored to announce the appointment of Charlotte Kremer, MD, MBA as the organization’s Chief Strategy Officer in a volunteer capacity, next to her volunteer role as Chair of the Board of Directors.
The Medical Affairs Professional Society (MAPS) and the Industry Pharmacists Organization (IPhO) are pleased to announce an important new strategic collaboration to help advance the careers of student pharmacists interested in the pharmaceutical industry, as well as Fellows and early-stage Industry Pharmacist professionals.
Influence is an inside-out game, requiring us to look inward before we lead outward.
if you start your day in work mode (4th & 5th gears), and you drive all day like that, you are going to burn out fast!
This paper synthesizes the views of senior global Medical Affairs leaders to provide a unified vision for the future of Medical Affairs. As such, this document represents the first consensus position by executives in Medical Affairs of our evolving roles, activities, and value in society, industry, teams and as individuals (detailing each in turn). By 2030, Medical Affairs will solidify its transition from executional to strategic, and the function will come to represent the voice of the patient within industry. We will not only disseminate evidence but also lead evidence generation activities that inform the real-world use of marketed and emerging treatments. Also in this time frame, we will solidify the role of Medical Affairs as industry’s external earpiece, gleaning insights from our interactions with the health care ecosystem that drive understanding of patient, payer, and provider needs and opinions. Throughout this evolution, the true north of Medical Affairs remains the same: to ensure that our science and technologies benefit patients.
Medical Affairs is a function within the biopharmaceutical, consumer healthcare, and MedTech industries that sits alongside other functions including Research & Development (R&D) and Commercial as one of the strategic pillars of the industry. R&D develops new drugs, devices and diagnostics; Commercial markets and sells these products; and Medical Affairs generates and communicates data that help healthcare professionals (HCPs), payors, policy makers and others make informed decisions that ensure the best use of treatments to benefit patients. In this way, Medical Affairs plays a vital role in providing scientific evidence and understanding to appropriately change clinical practice.
Just as there are many roles within R&D and Commercial, individuals working within Medical Affairs are responsible for many activities, especially including the following:
In this final article in the Leadership Perspectives series, John Pracyk interviews J&J leaders to explore a bold vision of career development that entails moving across sectors; namely, crossing over between Pharmaceuticals, Medical Devices, Vision, and Consumer Health.
This position paper is intended outline the roles and responsibilities expected of an MSL and provide clarity on the juxtaposition of MSLs and Sales representatives (SRs) when it comes to scientific exchange versus promotional messaging.
Here we explore how some of the top Medical Affairs leaders from Johnson & Johnson think about career leadership development opportunities and challenges.
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.